APA-referens

Marquardt, V., Theruvath, J., Pauck, D., Picard, D., Reifenberger, G., Borkhardt, A., . . . Mitra, S. (2020). IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS. Neuro Oncol.

Chicago-stil citat

Marquardt, Viktoria, et al. "IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS." Neuro Oncol 2020.

MLA-referens

Marquardt, Viktoria, et al. "IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS." Neuro Oncol 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.